Clinical Trial Update: Efficacy of Oral Zinc Administration as an Adjunct Therapy in New Pulmonary Tuberculosis (Category I) Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating oral zinc as an adjunct therapy for newly diagnosed Category I pulmonary tuberculosis. The current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Drugs mentioned

• ZINC (Zinc chloride)

Snippet

Sponsor: Ministry of Science and Technology, India | Conditions: Pulmonary Tuberculosis | Phase 3 | Status: UNKNOWN